Introducing a pharma company across Europe
Amarin Corporation, a mid-sized pharmaceutical company from the US, was on the brink of receiving EMA approval for its drug, prompting its decision to go it alone and establish a European presence in 12 markets. Amarin initially had a low profile in Europe, so building a reputation was crucial for rapid expansion.